Most Likely Diagnosis: Inflammatory Bowel Disease (Crohn's Disease) with Vitamin B12 Deficiency
The most likely diagnosis is inflammatory bowel disease affecting the ascending colon (likely Crohn's disease given the right-sided involvement), complicated by vitamin B12 deficiency as evidenced by elevated methylmalonic acid and homocysteine levels. The paradoxical iron findings (elevated total iron and iron saturation with normal ferritin) suggest anemia of chronic disease rather than iron deficiency anemia, which is consistent with active IBD 1, 2.
Diagnostic Reasoning
The Vitamin B12 Deficiency Pattern
The combination of elevated methylmalonic acid (MMA) and homocysteine is highly specific for vitamin B12 deficiency 3. When both MMA (>270 μM) and homocysteine (>15 μM) are elevated together, this confirms biochemical B12 deficiency with virtual certainty 4. This pattern rules out folate deficiency alone, as folate deficiency elevates homocysteine but not MMA 4.
In IBD patients, particularly those with ileal involvement or resection, B12 deficiency prevalence ranges from 5.6% to 38% 3. The ascending colon inflammation suggests possible terminal ileal involvement (Crohn's disease), which would directly impair B12 absorption 3.
The Iron Paradox
The iron profile is atypical but diagnostically important:
- Elevated total iron and iron saturation with normal ferritin indicates anemia of chronic disease (ACD), not iron deficiency 1, 5
- In the presence of inflammation, ferritin up to 100 μg/L may still reflect iron deficiency, but elevated iron saturation argues against this 1, 2
- This pattern is consistent with active IBD where inflammation drives hepcidin production, trapping iron in macrophages 6
Right-Sided Colonic Inflammation
Ascending colon involvement with edema and inflammation, while less common than left-sided disease, strongly suggests:
- Crohn's disease (which can affect any part of the GI tract and shows discontinuous involvement) 1
- Less likely ulcerative colitis (typically starts rectally and extends proximally in continuous fashion) 1
The negative H. pylori test excludes gastric causes of B12 malabsorption 7.
Recommended Management Algorithm
Immediate Actions (Week 1)
1. Confirm IBD Diagnosis:
- Complete ileocolonoscopy with biopsies from inflamed AND uninflamed segments (minimum 2 biopsies per segment) 1
- Obtain biopsies from terminal ileum specifically to assess for Crohn's disease 1
- Check fecal calprotectin if not already done 8
- Measure CRP, albumin, complete blood count 8
2. Initiate B12 Replacement Immediately:
- 1000 μg vitamin B12 intramuscular injection every other day for one week, then monthly for life 3
- This aggressive dosing is necessary given biochemical deficiency with elevated MMA and homocysteine 3
- Do NOT use oral B12 initially if ileal disease is present 3
3. Address Anemia:
- Since this appears to be anemia of chronic disease (elevated iron saturation), do NOT give oral iron supplements 9, 2
- Oral iron is contraindicated in active IBD as systemic inflammation inhibits absorption 9, 10
- Consider intravenous iron if hemoglobin <100 g/L or patient is symptomatic 2, 10
Week 2-4: Establish IBD Control
4. Initiate IBD-Specific Therapy:
- Treatment depends on disease severity and extent confirmed by colonoscopy
- For active disease: consider corticosteroids for induction, then maintenance therapy with immunomodulators or biologics 9
- Optimizing IBD control is the primary treatment for anemia of chronic disease 11
5. Nutritional Assessment:
- Check folate levels (folate deficiency can coexist and also elevates homocysteine) 11, 12
- If folate <9 nmol/L, supplement with folic acid 11
- Screen for vitamin D deficiency (common in IBD, especially with surgery) 9
- Assess for other micronutrient deficiencies 8
Ongoing Monitoring
6. Follow-up Laboratory Testing:
- Recheck MMA and homocysteine after 3 months of B12 therapy to confirm normalization 3, 4
- Annual B12 monitoring indefinitely 9, 3
- Monitor hemoglobin and iron indices every 3 months during active disease 2
- Once in remission, check every 6-12 months 2
7. Long-term B12 Management:
- Continue 1000 μg IM monthly indefinitely if >20 cm ileum involved or resected 3
- Oral B12 (1200-2400 μg daily) may be considered once in remission, but parenteral remains preferred 3
Critical Pitfalls to Avoid
Do NOT give oral iron in active IBD - This is ineffective and may worsen symptoms due to inflammation-mediated absorption blockade 9, 2, 10. Maximum 100 mg elemental iron daily only if disease is inactive 10.
Do NOT delay B12 replacement - Neurological complications can develop and may be irreversible if treatment is delayed 3. The elevated MMA/homocysteine pattern demands immediate action.
Do NOT assume normal ferritin excludes iron deficiency in inflammation - Ferritin up to 100 μg/L can still represent iron deficiency when inflammation is present 1, 5. However, the elevated iron saturation in this case argues against iron deficiency.
Do NOT overlook the need for complete ileocolonoscopy - Ascending colon inflammation requires assessment of the entire colon and terminal ileum to properly classify the IBD subtype and guide therapy 1.
Why This Matters for Outcomes
Untreated B12 deficiency leads to irreversible neurological damage, cognitive impairment, and increased cardiovascular risk from hyperhomocysteinemia 3, 12, 13. Uncontrolled IBD drives ongoing inflammation, perpetuating anemia of chronic disease and significantly impairing quality of life 11. Treating the underlying IBD is essential for resolving the anemia - iron supplementation alone will fail if inflammation persists 11.
The combination of aggressive B12 replacement, appropriate IBD therapy, and selective use of IV iron (not oral) when indicated will optimize both morbidity and quality of life outcomes 2, 3, 10.